The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson, Stephen D. Robinson, Karamallah Al-Yousuf, Adam E. Hendry, Darren W. Sexton, Victoria Sherwood (Lead / Corresponding author), Grant N. Wheeler

    Research output: Contribution to journalArticlepeer-review

    11 Citations (Scopus)
    127 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth'. Together they form a unique fingerprint.

    Medicine & Life Sciences